Venture Creation

Creating biotech companies from high-potential opportunities.

WBV works with VentriLinks and selected partners to identify under-realized biotech assets, IP, and startup opportunities that can become fundable therapeutics companies.

Selective Opportunity Activation

Venture creation focused on unlocking unrealized biotech value.

Biotech opportunities often fail to reach their full potential because of fragmented ownership, incomplete teams, weak commercialization strategy, misaligned positioning, or lack of coordinated execution.

WBV focuses on situations where active venture creation, structured execution, and aligned capital formation can unlock strategic value and create durable therapeutics companies.

Opportunity Sources

Diverse sourcing across biotech therapeutics ecosystems.

Academic IP and translational research

Under-commercialized startup assets

Non-core or deprioritized biopharma programs

Distressed or underappreciated biotech startups

Complementary assets with stronger combined value

Opportunities surfaced through VentriLinks and the VOA partner network

Venture Creation Process

Structured activation from opportunity identification to execution.

Opportunity Identification

High-potential opportunities are surfaced through VentriLinks, partner channels, academic institutions, investor relationships, and selected market intelligence.

Opportunity Intelligence

VentriLinks Opportunity Intelligence helps assess scientific relevance, differentiation, evidence quality, IP positioning, commercial potential, development feasibility, and partner fit.

Activation Pathway Selection

The appropriate activation pathway may include NewCo formation, licensing, commercialization strategy, structured investment, asset acquisition, carve-outs, or strategic restructuring.

Company Formation & Execution

WBV may help organize leadership, capitalization planning, financing strategy, partner configuration, operational structure, and execution roadmaps.

Have a biotech therapeutics asset or opportunity that may fit our venture creation model?

WBV selectively evaluates opportunities where venture creation, scientific differentiation, and execution alignment can create durable value.